Zacks Small Cap Has Negative Outlook of SBC FY2025 Earnings

Key Points

• Zacks Small Cap has lowered its FY2025 EPS estimate for SBC Medical Group from $0.65 to $0.53, while the current consensus estimate remains at $5.02 per share.
• SBC Medical Group reported quarterly earnings of $0.02 per share, missing analysts' expectations of $0.14 and also falling short on revenue, which was $43.36 million compared to expected $44.71 million.
• Institutional investors have been active, with major purchases made by firms including Geode Capital Management LLC and SBI Securities Co. Ltd., resulting in a total of 60.82% of the stock now held by institutional investors.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Zacks Small Cap dropped their FY2025 earnings per share (EPS) estimates for shares of SBC Medical Group in a note issued to investors on Tuesday, August 19th. Zacks Small Cap analyst M. Marin now expects that the company will post earnings per share of $0.53 for the year, down from their prior forecast of $0.65. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share.

Separately, Wall Street Zen downgraded SBC Medical Group from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 16th.

SBC Medical Group Stock Down 2.1%

Shares of NASDAQ SBC traded down $0.09 during mid-day trading on Wednesday, hitting $4.20. The company had a trading volume of 8,905 shares, compared to its average volume of 66,999. The business's 50-day simple moving average is $4.59 and its 200 day simple moving average is $4.19. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.98 and a quick ratio of 3.95. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $14.47. The company has a market capitalization of $436.30 million, a PE ratio of 13.13 and a beta of 1.27.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.12). The company had revenue of $43.36 million for the quarter, compared to analysts' expectations of $44.71 million. SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%.

Hedge Funds Weigh In On SBC Medical Group

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. XTX Topco Ltd acquired a new position in shares of SBC Medical Group in the 2nd quarter valued at approximately $64,000. New York State Common Retirement Fund bought a new position in shares of SBC Medical Group in the second quarter worth $104,000. SBI Securities Co. Ltd. boosted its stake in SBC Medical Group by 227.3% during the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock valued at $251,000 after buying an additional 37,623 shares in the last quarter. Finally, Geode Capital Management LLC bought a new position in SBC Medical Group during the second quarter valued at about $455,000. 60.82% of the stock is owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.